EUVIMEDObjevte EUVIMED
Open access

MA‐PEP : A novel anticancer peptide prediction framework with multimodal feature fusion based on attention mechanism

Xiao Liang, Haochen Zhao iD, Jianxin Wang

Protein Science · 2024-04 · 33 (4)

DOI: 10.1002/pro.4966 ↗

At a glance

Journal article in Protein Science, published online on 2024-03-27. Written by Xiao Liang and 2 co-authors. Institution: School of Computer Science and Engineering, Central South University, Changsha, China. Major MEDLINE topics: Benchmarking, Machine Learning. Cited 20 times so far (Crossref); 39 references. The full text is freely available in PubMed Central. Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China, NSFC Zhejiang Joint Fund for the Integration of Industrialization and Informatization.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

AntiCancer Peptides (ACPs) have emerged as promising therapeutic agents for cancer treatment. The time‐consuming and costly nature of wet‐lab discriminatory methods has spurred the development of various machine learning and deep learning‐based ACP classification methods. Nonetheless, current methods encountered challenges in efficiently integrating features from various peptide modalities, thereby limiting a more comprehensive understanding of ACPs and further restricting the improvement of prediction model performance. In this study, we introduce a novel ACP prediction method, MA‐PEP, which leverages multiple attention mechanisms for feature enhancement and fusion to improve ACP prediction. By integrating the enhanced molecular‐level chemical features and sequence information of peptides, MA‐PEP demonstrates superior prediction performance across several benchmark datasets, highlighting its efficacy in ACP prediction. Moreover, the visual analysis and case studies further demonstrate MA‐PEP's reliable feature extraction capability and its promise in the realm of ACP exploration. The code and datasets for MA‐PEP are available at https://github.com/liangxiaodata/MA-PEP .

Subjects

MeSH terms (MEDLINE)

BenchmarkingMachine LearningPeptides

Author keywords

anticancer peptideattention mechanismdrug discoveryfeature fusionmolecular fingerprint

Substances

Peptides

Authors and institutions

  • School of Computer Science and Engineering, Central South University, Changsha, China.
  • Hunan Provincial Key Lab on Bioinformatics, Central South University, Changsha, China.

ORCID profiles: Haochen Zhao

Funding

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • NSFC Zhejiang Joint Fund for the Integration of Industrialization and Informatization
  • Science and Technology Major Project of Changsha
  • 111 Project
  • Postdoctoral Fellowship Program of CPSF
  • Higher Education Discipline Innovation Project

Cite

APA

Liang, X., Zhao, H., & Wang, J. (2024). MA‐PEP : A novel anticancer peptide prediction framework with multimodal feature fusion based on attention mechanism. Protein Science, 33(4). https://doi.org/10.1002/pro.4966

Vancouver

Liang X, Zhao H, Wang J. MA‐PEP : A novel anticancer peptide prediction framework with multimodal feature fusion based on attention mechanism. Protein Science. 2024;33(4). doi:10.1002/pro.4966

BibTeX
@article{Liang2024,
  author = {Liang, Xiao and Zhao, Haochen and Wang, Jianxin},
  title = {MA‐PEP : A novel anticancer peptide prediction framework with multimodal feature fusion based on attention mechanism},
  journal = {Protein Science},
  year = {2024},
  volume = {33},
  number = {4},
  doi = {10.1002/pro.4966}
}
Start for free →